Contact: Bill Schaller
Dana-Farber Cancer Institute
Caption: Ursula Matulonis, M.D., and colleagues say the technique used to identify a new subtype of ovarian cancer may prove useful in determining how a patient's cancer might respond to a specific treatments.
Credit: Sam Ogden
Usage Restrictions: None
Related news release: New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs